The document announces a market research report from Global Markets Direct on Nabriva Therapeutics AG's product pipeline as of 2012. The report provides an overview of Nabriva's research areas and developmental pipeline, including projects in clinical and pre-clinical stages. It describes two of Nabriva's lead candidates, BC-3781 and BC-7013, and their mechanisms of action and development progress. The document provides links to purchase the full report and other related pharmaceutical pipeline reviews.